We are in an exciting and challenging period of advance in the clinical neurosciences. Computerized axial tomography will surely rank with pneumography and angiography as a landmark contribution to neurologic diagnosis. Elucidation of the enzymatic defects responsible for certain heritable diseases continues, with substantial promise for definitive management. Increased understanding of the nature and role of neurotransmitters has created the basis for targeted pharmacologic therapy. Pathogenesis of the demyelinating diseases may be finally revealed through study of disordered immunologic response. Behavioral neurology has increased the knowledge of cortical function. The application of new techniques of radiographic localization and of regional blood flow with increasingly sophisticated tests of function will further complement and extend the studies of experimental work.
Other advances have led to enhanced care in current clinical application. The determination of anticonvulsant drug levels has substantially improved control of epilepsy. The use of antifibrinolytic agents has resulted in
Van Allen MW. Perspectives and Plans. Arch Neurol. 1976;33(10):667. doi:10.1001/archneur.1976.00500100001002
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.